The resistance of MICA/B-positive pancreatic cancer to NK-92 cell killing could be due to the inhibitory effect of co-expressed HLA-G antigen that suppresses NK cell function [29-31]. The gene discussed is HLA-G; the disease is pancreatic neoplasm.